Market revenue in 2023 | USD 16.2 million |
Market revenue in 2030 | USD 28.9 million |
Growth rate | 8.6% (CAGR from 2023 to 2030) |
Largest segment | Human donor tissue-derived products |
Fastest growing segment | Human Donor Tissue-Derived Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 66.67% in 2023. Horizon Databook has segmented the Canada biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
The medical device outsourcing market in Canada is highly competitive, with several key players operating in the country. Some major players are Global Regulatory Partners, Sterigenics U.S., LLC (GTCR, LLC), and Celestica, Inc.
These players compete on factors such as product quality, reliability, capacity, and cost-effectiveness to attract and retain clients. Moreover, increasing government funding for developing new medical devices. For instance, in October 2023, the federal government disclosed an investment of nearly USD 3 million in six medical & technology companies in Nova Scotia.
This financial support is intended to assist these companies in expanding their operations and improving their products. Adaptiiv Medical Technologies, a company specializing in the production of 3D-printed accessories utilized in radiotherapy, has been granted USD 963,164 as part of the investment.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada biological skin substitutes market , including forecasts for subscribers. This country databook contains high-level insights into Canada biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account